Positive Result: Clinical Utility and Interpretations
Immune/Antibody
W
View full entry on WUSTL Neuromuscular
antibody/galop.htm#Positive Result: Clinical Utility and Interpretations
Overview
From WUSTL NeuromuscularSpecificity: >90% Diagnostic: May be only positive diagnostic test in a patient with a neuropathy and gait disorder This is especially helpful in patients whose neuropathy or gait disorder would otherwise be labeled as idiopathic. Provides independent support for a diagnosis of an immune-mediated sensory-motor or sensory polyneuropathy. The neuropathy may be either demyelinating or axonal. Suggests treatment possibilities when gait disorder & neuropathy is disabling Prognostic: Suggests that the disability will most often be slowly progressive over a period of years. Treatment: Indicates direc
Related Conditions
Shared genesAntibodies vs Glycolipids & Glycoproteins
GM1MAGGQ1B
Axonal Sensory Neuropathies with Serum IgM binding to Trisulfated Heparin Disaccharide (TS-HDS)
HDSDISACCHARIDEMAG
I. Clinical Indications for Measurement of anti-MAG antibodies
MAG
II. Results with Specificity and Sensitivity for Sensory-Motor Neuropathies
MAG
III. Testing Laboratory Standards for anti-MAG Antibodies.
MAG
IV. Interpretations of Confirmed Positive anti-MAG Results
MAG
IV. Positive Result: Clinical Utility and Interpretations
MAG
Monoclonal Gammopathies of Unknown Significance (& Other)
MAGGD1AHDS
External Resources
Data sourced from the Washington University Neuromuscular Disease Center. For clinical use, always refer to primary sources.